Center for Dementia Research, Nathan Kline Institute, Orangeburg, NY 10962, USA; Department of Psychiatry, New York University Grossman School of Medicine, New York, NY 10016, USA; Department of Neuroscience and Physiology, New York University Grossman School of Medicine, New York, NY 10016, USA; NYU Neuroscience Institute, New York University Grossman School of Medicine, New York, NY 10016, USA.
Program in Chemical Biology, Sloan Kettering Institute, New York, NY 10065, USA.
Trends Pharmacol Sci. 2023 Jan;44(1):20-33. doi: 10.1016/j.tips.2022.10.006. Epub 2022 Nov 20.
Diseases are manifestations of complex changes in protein-protein interaction (PPI) networks whereby stressors, genetic, environmental, and combinations thereof, alter molecular interactions and perturb the individual from the level of cells and tissues to the entire organism. Targeting stressor-induced dysfunctions in PPI networks has therefore become a promising but technically challenging frontier in therapeutics discovery. This opinion provides a new framework based upon disrupting epichaperomes - pathological entities that enable dysfunctional rewiring of PPI networks - as a mechanism to revert context-specific PPI network dysfunction to a normative state. We speculate on the implications of recent research in this area for a precision medicine approach to detecting and treating complex diseases, including cancer and neurodegenerative disorders.
疾病是蛋白质-蛋白质相互作用(PPI)网络复杂变化的表现形式,其中应激源、遗传、环境及其组合改变了分子相互作用,并使个体从细胞和组织水平到整个生物体受到干扰。因此,靶向 PPI 网络中应激诱导的功能障碍已成为治疗发现中一个有前途但技术上具有挑战性的前沿领域。本观点提供了一个基于破坏表观组 - 病理实体,使 PPI 网络的功能失调重新布线 - 的新框架,作为将特定于上下文的 PPI 网络功能障碍恢复到正常状态的机制。我们推测该领域最近的研究对检测和治疗复杂疾病(包括癌症和神经退行性疾病)的精准医疗方法的意义。